Click for best price
Super Generic Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Super Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Super Generic Drugs. This report contains market size and forecasts of Super Generic Drugs in global, including the following market information:
Global Super Generic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Super Generic Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Super Generic Drugs companies in 2022 (%)
The global Super Generic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Traditional Generic Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Super Generic Drugs include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Super Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Super Generic Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Super Generic Drugs Market Segment Percentages, by Type, 2022 (%)
Traditional Generic Drugs
Biosimilars
Global Super Generic Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Super Generic Drugs Market Segment Percentages, by Application, 2022 (%)
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Global Super Generic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Super Generic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Super Generic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Super Generic Drugs revenues share in global market, 2022 (%)
Key companies Super Generic Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Super Generic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Super Generic Drugs, market overview.
Chapter 2: Global Super Generic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Super Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Super Generic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Super Generic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Super Generic Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
121 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Super Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Super Generic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Super Generic Drugs Overall Market Size
2.1 Global Super Generic Drugs Market Size: 2022 VS 2030
2.2 Global Super Generic Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Super Generic Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Super Generic Drugs Players in Global Market
3.2 Top Global Super Generic Drugs Companies Ranked by Revenue
3.3 Global Super Generic Drugs Revenue by Companies
3.4 Global Super Generic Drugs Sales by Companies
3.5 Global Super Generic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Super Generic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Super Generic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Super Generic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Super Generic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Super Generic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Super Generic Drugs Market Size Markets, 2022 & 2030
4.1.2 Traditional Generic Drugs
4.1.3 Biosimilars
4.2 By Type - Global Super Generic Drugs Revenue & Forecasts
4.2.1 By Type - Global Super Generic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Super Generic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Super Generic Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Super Generic Drugs Sales & Forecasts
4.3.1 By Type - Global Super Generic Drugs Sales, 2018-2023
4.3.2 By Type - Global Super Generic Drugs Sales, 2024-2030
4.3.3 By Type - Global Super Generic Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Super Generic Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Super Generic Drugs Market Size, 2022 & 2030
5.1.2 CNS
5.1.3 Cardiovascular
5.1.4 Genitourinary/Hormonal Drugs
5.1.5 Respiratory
5.1.6 Rheumatology
5.1.7 Diabetes
5.1.8 Oncology
5.1.9 Others
5.2 By Application - Global Super Generic Drugs Revenue & Forecasts
5.2.1 By Application - Global Super Generic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Super Generic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Super Generic Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Super Generic Drugs Sales & Forecasts
5.3.1 By Application - Global Super Generic Drugs Sales, 2018-2023
5.3.2 By Application - Global Super Generic Drugs Sales, 2024-2030
5.3.3 By Application - Global Super Generic Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Super Generic Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Super Generic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Super Generic Drugs Revenue & Forecasts
6.2.1 By Region - Global Super Generic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Super Generic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Super Generic Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Super Generic Drugs Sales & Forecasts
6.3.1 By Region - Global Super Generic Drugs Sales, 2018-2023
6.3.2 By Region - Global Super Generic Drugs Sales, 2024-2030
6.3.3 By Region - Global Super Generic Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Super Generic Drugs Revenue, 2018-2030
6.4.2 By Country - North America Super Generic Drugs Sales, 2018-2030
6.4.3 US Super Generic Drugs Market Size, 2018-2030
6.4.4 Canada Super Generic Drugs Market Size, 2018-2030
6.4.5 Mexico Super Generic Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Super Generic Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Super Generic Drugs Sales, 2018-2030
6.5.3 Germany Super Generic Drugs Market Size, 2018-2030
6.5.4 France Super Generic Drugs Market Size, 2018-2030
6.5.5 U.K. Super Generic Drugs Market Size, 2018-2030
6.5.6 Italy Super Generic Drugs Market Size, 2018-2030
6.5.7 Russia Super Generic Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Super Generic Drugs Market Size, 2018-2030
6.5.9 Benelux Super Generic Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Super Generic Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Super Generic Drugs Sales, 2018-2030
6.6.3 China Super Generic Drugs Market Size, 2018-2030
6.6.4 Japan Super Generic Drugs Market Size, 2018-2030
6.6.5 South Korea Super Generic Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Super Generic Drugs Market Size, 2018-2030
6.6.7 India Super Generic Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Super Generic Drugs Revenue, 2018-2030
6.7.2 By Country - South America Super Generic Drugs Sales, 2018-2030
6.7.3 Brazil Super Generic Drugs Market Size, 2018-2030
6.7.4 Argentina Super Generic Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Super Generic Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Super Generic Drugs Sales, 2018-2030
6.8.3 Turkey Super Generic Drugs Market Size, 2018-2030
6.8.4 Israel Super Generic Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Super Generic Drugs Market Size, 2018-2030
6.8.6 UAE Super Generic Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Super Generic Drugs Major Product Offerings
7.1.4 Teva Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Novartis - Sandoz
7.2.1 Novartis - Sandoz Company Summary
7.2.2 Novartis - Sandoz Business Overview
7.2.3 Novartis - Sandoz Super Generic Drugs Major Product Offerings
7.2.4 Novartis - Sandoz Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Novartis - Sandoz Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Super Generic Drugs Major Product Offerings
7.3.4 Mylan Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Super Generic Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Aspen
7.5.1 Aspen Company Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Super Generic Drugs Major Product Offerings
7.5.4 Aspen Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Aspen Key News & Latest Developments
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Super Generic Drugs Major Product Offerings
7.6.4 Fresenius Kabi Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Fresenius Kabi Key News & Latest Developments
7.7 Pfizer (Hospira)
7.7.1 Pfizer (Hospira) Company Summary
7.7.2 Pfizer (Hospira) Business Overview
7.7.3 Pfizer (Hospira) Super Generic Drugs Major Product Offerings
7.7.4 Pfizer (Hospira) Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer (Hospira) Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Super Generic Drugs Major Product Offerings
7.8.4 Sanofi Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Aurobindo
7.9.1 Aurobindo Company Summary
7.9.2 Aurobindo Business Overview
7.9.3 Aurobindo Super Generic Drugs Major Product Offerings
7.9.4 Aurobindo Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Aurobindo Key News & Latest Developments
7.10 Lupin
7.10.1 Lupin Company Summary
7.10.2 Lupin Business Overview
7.10.3 Lupin Super Generic Drugs Major Product Offerings
7.10.4 Lupin Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Lupin Key News & Latest Developments
7.11 Dr. Reddy's
7.11.1 Dr. Reddy's Company Summary
7.11.2 Dr. Reddy's Super Generic Drugs Business Overview
7.11.3 Dr. Reddy's Super Generic Drugs Major Product Offerings
7.11.4 Dr. Reddy's Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Dr. Reddy's Key News & Latest Developments
7.12 Apotex
7.12.1 Apotex Company Summary
7.12.2 Apotex Super Generic Drugs Business Overview
7.12.3 Apotex Super Generic Drugs Major Product Offerings
7.12.4 Apotex Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Apotex Key News & Latest Developments
7.13 Cipla
7.13.1 Cipla Company Summary
7.13.2 Cipla Super Generic Drugs Business Overview
7.13.3 Cipla Super Generic Drugs Major Product Offerings
7.13.4 Cipla Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Cipla Key News & Latest Developments
7.14 ENDO (Par Pharmaceutical)
7.14.1 ENDO (Par Pharmaceutical) Company Summary
7.14.2 ENDO (Par Pharmaceutical) Business Overview
7.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Major Product Offerings
7.14.4 ENDO (Par Pharmaceutical) Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.14.5 ENDO (Par Pharmaceutical) Key News & Latest Developments
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Company Summary
7.15.2 Stada Arzneimittel Business Overview
7.15.3 Stada Arzneimittel Super Generic Drugs Major Product Offerings
7.15.4 Stada Arzneimittel Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Stada Arzneimittel Key News & Latest Developments
7.16 Krka Group
7.16.1 Krka Group Company Summary
7.16.2 Krka Group Business Overview
7.16.3 Krka Group Super Generic Drugs Major Product Offerings
7.16.4 Krka Group Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Krka Group Key News & Latest Developments
7.17 Nichi-Iko Pharmaceutical
7.17.1 Nichi-Iko Pharmaceutical Company Summary
7.17.2 Nichi-Iko Pharmaceutical Business Overview
7.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Major Product Offerings
7.17.4 Nichi-Iko Pharmaceutical Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Nichi-Iko Pharmaceutical Key News & Latest Developments
7.18 Valeant
7.18.1 Valeant Company Summary
7.18.2 Valeant Business Overview
7.18.3 Valeant Super Generic Drugs Major Product Offerings
7.18.4 Valeant Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Valeant Key News & Latest Developments
7.19 Zydus Cadila
7.19.1 Zydus Cadila Company Summary
7.19.2 Zydus Cadila Business Overview
7.19.3 Zydus Cadila Super Generic Drugs Major Product Offerings
7.19.4 Zydus Cadila Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Zydus Cadila Key News & Latest Developments
7.20 Hikma
7.20.1 Hikma Company Summary
7.20.2 Hikma Business Overview
7.20.3 Hikma Super Generic Drugs Major Product Offerings
7.20.4 Hikma Super Generic Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Hikma Key News & Latest Developments
8 Global Super Generic Drugs Production Capacity, Analysis
8.1 Global Super Generic Drugs Production Capacity, 2018-2030
8.2 Super Generic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Super Generic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Super Generic Drugs Supply Chain Analysis
10.1 Super Generic Drugs Industry Value Chain
10.2 Super Generic Drugs Upstream Market
10.3 Super Generic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Super Generic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Super Generic Drugs in Global Market
Table 2. Top Super Generic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Super Generic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Super Generic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Super Generic Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Super Generic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Super Generic Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Super Generic Drugs Product Type
Table 9. List of Global Tier 1 Super Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Super Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Super Generic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Super Generic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Super Generic Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Super Generic Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Super Generic Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Super Generic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Super Generic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Super Generic Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Super Generic Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Super Generic Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Super Generic Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Super Generic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Super Generic Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Super Generic Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Super Generic Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Super Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Super Generic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Super Generic Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Super Generic Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Super Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Super Generic Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Super Generic Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Super Generic Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Super Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Super Generic Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Super Generic Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Super Generic Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Super Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Super Generic Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Super Generic Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Super Generic Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Super Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Super Generic Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Super Generic Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Super Generic Drugs Sales, (K Units), 2024-2030
Table 46. Teva Company Summary
Table 47. Teva Super Generic Drugs Product Offerings
Table 48. Teva Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Teva Key News & Latest Developments
Table 50. Novartis - Sandoz Company Summary
Table 51. Novartis - Sandoz Super Generic Drugs Product Offerings
Table 52. Novartis - Sandoz Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Novartis - Sandoz Key News & Latest Developments
Table 54. Mylan Company Summary
Table 55. Mylan Super Generic Drugs Product Offerings
Table 56. Mylan Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Mylan Key News & Latest Developments
Table 58. Sun Pharmaceutical Company Summary
Table 59. Sun Pharmaceutical Super Generic Drugs Product Offerings
Table 60. Sun Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sun Pharmaceutical Key News & Latest Developments
Table 62. Aspen Company Summary
Table 63. Aspen Super Generic Drugs Product Offerings
Table 64. Aspen Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Aspen Key News & Latest Developments
Table 66. Fresenius Kabi Company Summary
Table 67. Fresenius Kabi Super Generic Drugs Product Offerings
Table 68. Fresenius Kabi Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Fresenius Kabi Key News & Latest Developments
Table 70. Pfizer (Hospira) Company Summary
Table 71. Pfizer (Hospira) Super Generic Drugs Product Offerings
Table 72. Pfizer (Hospira) Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Pfizer (Hospira) Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Super Generic Drugs Product Offerings
Table 76. Sanofi Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. Aurobindo Company Summary
Table 79. Aurobindo Super Generic Drugs Product Offerings
Table 80. Aurobindo Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Aurobindo Key News & Latest Developments
Table 82. Lupin Company Summary
Table 83. Lupin Super Generic Drugs Product Offerings
Table 84. Lupin Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Lupin Key News & Latest Developments
Table 86. Dr. Reddy's Company Summary
Table 87. Dr. Reddy's Super Generic Drugs Product Offerings
Table 88. Dr. Reddy's Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Dr. Reddy's Key News & Latest Developments
Table 90. Apotex Company Summary
Table 91. Apotex Super Generic Drugs Product Offerings
Table 92. Apotex Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Apotex Key News & Latest Developments
Table 94. Cipla Company Summary
Table 95. Cipla Super Generic Drugs Product Offerings
Table 96. Cipla Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Cipla Key News & Latest Developments
Table 98. ENDO (Par Pharmaceutical) Company Summary
Table 99. ENDO (Par Pharmaceutical) Super Generic Drugs Product Offerings
Table 100. ENDO (Par Pharmaceutical) Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. ENDO (Par Pharmaceutical) Key News & Latest Developments
Table 102. Stada Arzneimittel Company Summary
Table 103. Stada Arzneimittel Super Generic Drugs Product Offerings
Table 104. Stada Arzneimittel Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Stada Arzneimittel Key News & Latest Developments
Table 106. Krka Group Company Summary
Table 107. Krka Group Super Generic Drugs Product Offerings
Table 108. Krka Group Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Krka Group Key News & Latest Developments
Table 110. Nichi-Iko Pharmaceutical Company Summary
Table 111. Nichi-Iko Pharmaceutical Super Generic Drugs Product Offerings
Table 112. Nichi-Iko Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Nichi-Iko Pharmaceutical Key News & Latest Developments
Table 114. Valeant Company Summary
Table 115. Valeant Super Generic Drugs Product Offerings
Table 116. Valeant Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Valeant Key News & Latest Developments
Table 118. Zydus Cadila Company Summary
Table 119. Zydus Cadila Super Generic Drugs Product Offerings
Table 120. Zydus Cadila Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Zydus Cadila Key News & Latest Developments
Table 122. Hikma Company Summary
Table 123. Hikma Super Generic Drugs Product Offerings
Table 124. Hikma Super Generic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Hikma Key News & Latest Developments
Table 126. Super Generic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Super Generic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Super Generic Drugs Production by Region, 2018-2023 (K Units)
Table 129. Global Super Generic Drugs Production by Region, 2024-2030 (K Units)
Table 130. Super Generic Drugs Market Opportunities & Trends in Global Market
Table 131. Super Generic Drugs Market Drivers in Global Market
Table 132. Super Generic Drugs Market Restraints in Global Market
Table 133. Super Generic Drugs Raw Materials
Table 134. Super Generic Drugs Raw Materials Suppliers in Global Market
Table 135. Typical Super Generic Drugs Downstream
Table 136. Super Generic Drugs Downstream Clients in Global Market
Table 137. Super Generic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Super Generic Drugs Segment by Type in 2022
Figure 2. Super Generic Drugs Segment by Application in 2022
Figure 3. Global Super Generic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Super Generic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Super Generic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Super Generic Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Super Generic Drugs Revenue in 2022
Figure 9. By Type - Global Super Generic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Super Generic Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Super Generic Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Super Generic Drugs Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Super Generic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Super Generic Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Super Generic Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Super Generic Drugs Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Super Generic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Super Generic Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Super Generic Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Super Generic Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Super Generic Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Super Generic Drugs Sales Market Share, 2018-2030
Figure 23. US Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Super Generic Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Super Generic Drugs Sales Market Share, 2018-2030
Figure 28. Germany Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Super Generic Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Super Generic Drugs Sales Market Share, 2018-2030
Figure 37. China Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Super Generic Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Super Generic Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Super Generic Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Super Generic Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Super Generic Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Super Generic Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Super Generic Drugs by Region, 2022 VS 2030
Figure 54. Super Generic Drugs Industry Value Chain
Figure 55. Marketing Channels
